Dimed S.A. Distribuidora de Medicamentos - Asset Resilience Ratio
Dimed S.A. Distribuidora de Medicamentos (PNVL3) has an Asset Resilience Ratio of 7.83% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2000–2025)
This chart shows how Dimed S.A. Distribuidora de Medicamentos's Asset Resilience Ratio has changed over time. Check Dimed S.A. Distribuidora de Medicamentos strategic asset allocation index to assess the company's strategic physical and investment asset allocation.
Liquid Assets Composition Over Time
This chart breaks down Dimed S.A. Distribuidora de Medicamentos's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see how much is Dimed S.A. Distribuidora de Medicamentos worth.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | R$0.00 | 0% |
| Short-term Investments | R$286.73 Million | 7.83% |
| Total Liquid Assets | R$286.73 Million | 7.83% |
Asset Resilience Insights
- Limited Liquidity: Dimed S.A. Distribuidora de Medicamentos maintains only 7.83% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Dimed S.A. Distribuidora de Medicamentos Industry Peers by Asset Resilience Ratio
Compare Dimed S.A. Distribuidora de Medicamentos's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Biogen Inc
NASDAQ:BIIB |
Drug Manufacturers - General | 2.74% |
|
Virbac SA
PA:VIRP |
Drug Manufacturers - General | 0.23% |
|
Aurora Optoelectronics Co Ltd
SHG:600666 |
Drug Manufacturers - General | 5.89% |
|
NanJing Pharmaceutical Co Ltd
SHG:600713 |
Drug Manufacturers - General | 0.85% |
|
Firebrick Pharma Ltd
AU:FRE |
Drug Manufacturers - General | 0.29% |
|
Eli Lilly and Company
SA:LILY34 |
Drug Manufacturers - General | 8.63% |
|
Pfizer Inc
SA:PFIZ34 |
Drug Manufacturers - General | 5.48% |
|
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SHG:600436 |
Drug Manufacturers - General | 17.40% |
Annual Asset Resilience Ratio for Dimed S.A. Distribuidora de Medicamentos (2000–2025)
The table below shows the annual Asset Resilience Ratio data for Dimed S.A. Distribuidora de Medicamentos.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 10.70% | R$410.05 Million ≈ $80.46 Million |
R$3.83 Billion ≈ $751.62 Million |
+4.56pp |
| 2024-12-31 | 6.15% | R$207.59 Million ≈ $40.73 Million |
R$3.38 Billion ≈ $662.72 Million |
-1.57pp |
| 2023-12-31 | 7.72% | R$237.48 Million ≈ $46.60 Million |
R$3.08 Billion ≈ $603.86 Million |
+2.14pp |
| 2022-12-31 | 5.58% | R$152.52 Million ≈ $29.93 Million |
R$2.73 Billion ≈ $536.29 Million |
-3.03pp |
| 2021-12-31 | 8.61% | R$205.00 Million ≈ $40.22 Million |
R$2.38 Billion ≈ $467.21 Million |
-11.01pp |
| 2020-12-31 | 19.62% | R$430.63 Million ≈ $84.50 Million |
R$2.19 Billion ≈ $430.58 Million |
+15.68pp |
| 2019-12-31 | 3.95% | R$57.67 Million ≈ $11.32 Million |
R$1.46 Billion ≈ $286.53 Million |
+1.49pp |
| 2018-12-31 | 2.46% | R$24.58 Million ≈ $4.82 Million |
R$1.00 Billion ≈ $196.29 Million |
-2.08pp |
| 2017-12-31 | 4.54% | R$43.09 Million ≈ $8.46 Million |
R$950.17 Million ≈ $186.44 Million |
+3.48pp |
| 2016-12-31 | 1.05% | R$8.62 Million ≈ $1.69 Million |
R$820.97 Million ≈ $161.09 Million |
+0.03pp |
| 2015-12-31 | 1.02% | R$7.73 Million ≈ $1.52 Million |
R$759.97 Million ≈ $149.12 Million |
-1.38pp |
| 2014-12-31 | 2.40% | R$17.26 Million ≈ $3.39 Million |
R$719.27 Million ≈ $141.13 Million |
+0.52pp |
| 2013-12-31 | 1.88% | R$11.28 Million ≈ $2.21 Million |
R$599.89 Million ≈ $117.71 Million |
-1.93pp |
| 2012-12-31 | 3.81% | R$19.09 Million ≈ $3.75 Million |
R$500.82 Million ≈ $98.27 Million |
-8.16pp |
| 2009-12-31 | 11.97% | R$39.88 Million ≈ $7.83 Million |
R$333.08 Million ≈ $65.36 Million |
+11.71pp |
| 2008-12-31 | 0.26% | R$716.00K ≈ $140.49K |
R$275.75 Million ≈ $54.11 Million |
-4.66pp |
| 2007-12-31 | 4.92% | R$12.47 Million ≈ $2.45 Million |
R$253.46 Million ≈ $49.73 Million |
-2.78pp |
| 2006-12-31 | 7.70% | R$18.03 Million ≈ $3.54 Million |
R$234.29 Million ≈ $45.97 Million |
+0.74pp |
| 2005-12-31 | 6.96% | R$15.13 Million ≈ $2.97 Million |
R$217.51 Million ≈ $42.68 Million |
-1.01pp |
| 2004-12-31 | 7.96% | R$14.33 Million ≈ $2.81 Million |
R$179.97 Million ≈ $35.31 Million |
-4.76pp |
| 2003-12-31 | 12.72% | R$21.88 Million ≈ $4.29 Million |
R$172.02 Million ≈ $33.75 Million |
-1.24pp |
| 2002-12-31 | 13.96% | R$20.27 Million ≈ $3.98 Million |
R$145.21 Million ≈ $28.49 Million |
-4.04pp |
| 2001-12-31 | 18.00% | R$28.17 Million ≈ $5.53 Million |
R$156.51 Million ≈ $30.71 Million |
+2.73pp |
| 2000-12-31 | 15.27% | R$22.56 Million ≈ $4.43 Million |
R$147.79 Million ≈ $29.00 Million |
-- |
About Dimed S.A. Distribuidora de Medicamentos
Dimed S.A. Distribuidora de Medicamentos sells medicines, perfumeries, personal hygiene and beauty products, cosmetics and dermocosmetics in Brazil. It sells its products through physical stores in retail industry. Dimed S.A. Distribuidora de Medicamentos was founded in 1920 and is headquartered in Eldorado do Sul, Brazil.